Study finds adverse respiratory outcomes for older people with COPD taking benzodiazepines
A group of drugs commonly prescribed for insomnia, anxiety and breathing issues “significantly increase the risk” that older people with chronic obstructive pulmonary disease, or COPD, need to visit a doctor or Emergency Department for respiratory reasons,...GlaxoSmithKline Announces Approval In Canada For Incruse…
4/17/2014 4:37:25 PM MISSISSAUGA, ON, April 17, 2014 /CNW/ – GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Incruse™ Ellipta™ (umeclidinium, as umeclidinium bromide) has received market authorisation in Canada for the long-term once-daily maintenance...GlaxoSmithKline, Genmab A/S Wins FDA Approval For Arzerra As…
4/17/2014 4:09:08 PM GlaxoSmithKline And Genmab Receive FDA Approval For Arzerra® (Ofatumumab) As First-Line Treatment In Combination With Chlorambucil For Patients With Chronic Lymphocytic Leukaemia (CLL) For Whom Fludarabine-Based Therapy Is Considered...